Search results for: “Biopharmaceutical”
-
AstraZeneca PLC
•
AstraZeneca PLC is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England. Its…
-
AstraZeneca announces a three-tranche $3 billion global bond offering
•
LONDON: AstraZeneca PLC announces that, on 3 August 2020, it priced a three tranche global bond offering totalling…
-
Spectrum Pharmaceuticals announces proposed public offering of common stock
•
HENDERSON: Spectrum Pharmaceuticals Inc. intends to offer and sell shares of its common stock in an underwritten registered…
-
Kemal Malik appointed non-executive director at Syncona Ltd
•
LONDON: Syncona Ltd, a leading healthcare company, announces the appointment of Dr Kemal Malik as a Non-Executive Director…
-
Faron receives €2.1 million loan, from Business Finland for Traumakine manufacturing
•
TURKU, FINLAND: Faron Pharmaceuticals Oy, the clinical stage biopharmaceutical company, announced plans to initiate a new state of…
-
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine
•
LONDON: AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and…
-
Faron Pharmaceuticals selected for €2.5 million grant from European Innovation Council
•
TURKU, FINLAND: Faron Pharmaceuticals Oy, the clinical stage biopharmaceutical company, has been selected to receive a €2.5 million…
-
e-therapeutics collaborates with Galapagos to discover new therapeutic strategies
•
OXFORD: e-therapeutics plc has entered a collaboration agreement with Galapagos NV to identify new therapeutic approaches to modulate…
-
Lonza appoints Pierre-Alain Ruffieux as new Chief Executive Officer
•
BASEL, SWITZERLAND: The Board of Lonza announced today that Pierre-Alain Ruffieux has been appointed Chief Executive Officer effective…
-
Bevespi Aerosphere approved in China for patients with COPD
•
LONDON: AstraZeneca’s Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in China as a maintenance treatment to relieve symptoms…
-
AstraZeneca to sublicense global Movantik rights to RedHill Biopharma
•
LONDON: AstraZeneca Plc has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel,…
-
AstraZeneca divests rights to Seroquel and Seroquel XR for $35 million
•
LONDON, UK: AstraZeneca has agreed to sell the commercial rights to Seroquel and Seroquel XR in the US…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.